Melamed ML, Eustace JA, Plantinga LC, Jaar BG, Fink NE, Parekh RS, Coresh J, Yang Z, Cantor T, Powe NR. Third-generation parathyroid hormone assays and all-cause mortality in incident dialysis patients: The CHOICE Study. NDT, 23:1650-1658, 2008.
Matanoski GM, Tonascia JA, Correa-Villaseñor A, Yates KC, Fink N, Elliott E, Sanders B, Lantry D. Cancer risks and low-level radiation in US shipyard workers. J Radiat Res 49:83-81, 2008.
Wang NY, Eisenberg LS, Johnson KC, Fink NE, Tobey EA, Quittner AL, Niparko JK and the CDaCI Investigative Team. Tracking development of speech recognition: longitudinal data from hierarchical assessments in CDaCI. Otology & Neurotology, 29:240-245, 2008.
Zwolan TA, O’Sullivan MB, Fink NE, Niparko JK, and the CDaCI Investigative Team. Electrical charge requirements of pediatric cochlear implant recipients enrolled in the CDaCI. Otology & Neurotology, 29:143-148, 2008.
Lin FR, Wang NY, Fink NE, Quittner AL, Eisenberg LS, Tobey EA, Niparko JK, and the CDaCI Investigative Team. Assessing the use of speech and language measures in relation to parental perceptions of development after early cochlear implantation. Otology & Neurotology, 29:208-213, 2008.
Jaar BG, Plantinga LC, Astor BC, Fink NE, Longenecker JC, Tracy RP, Marcovina SM, Powe NR, Coresh J. Novel and traditional cardiovascular risk factors for peripheral arterial disease in incident dialysis patients. ACKD, 14:304-313, 2007.
Fink NE, Wang NY, Visaya J, Niparko JK, Quittner A, Eisenberg LS, Tobey EA and the CDaCI Investigative Team. Childhood Development after Cochlear Implantation (CDaCI) Study: Design and baseline characteristics. Cochlear Implants Int, 8:92-116, 2007.
Merkin SS, Cavanaugh K, Longenecker JC, Fink NE, Levey AS, Powe NR. Agreement of self-reported comorbid conditions with medical and physician reports varied by disease among end-stage renal disease patients. J Clin Epidemiol, 60: 634-642, 2007.
Gupta R, Plantinga LC, Fink NE, Melamed ML, Coresh J, Fox CS, Levin NW, Powe NR. Statin use and hospitalization for sepsis in patients with chronic kidney disease. JAMA, 297:1455-1464, 2007.
Plantinga LC, Fink NE, Levin NW, Jaar BG, Coresh J, Levey AS, Klag MJ, Powe NR. Early, intermediate, and long-term risk factors for mortality in incident dialysis patients: the Choices for Healthy Outcomes in Caring for ESRD (CHOICE) Study. Am J Kidney Dis, 49:831-840, 2007 .
Plantinga LC, Fink NE, Jaar BG, Huang I-C, Wu AW, Meyer KB, Powe NR. Relation between level of change of hemoglobin and generic and disease-specific quality of life measures in hemodialysis. Qual Life Res, 16:755-765, 2007.
Plantinga LC, Fink NE, Bass EB, Boulware LE, Meyer KB, Powe NR. Preferences for current health and their association with outcomes in patients with kidney disease. Med Care, 45:230-237, 2007 .
Liu YM, Berthier-Schaad Y, Plantinga L, Fink NE, Tracy RP, Kao WH, Klag MJ, Smith MW, Coresh J. Functional variants in the lymphotoxin alpha gene predict cardiovascular disease in dialysis patients. JASN, 17:3158-3166, 2007.
Plantinga LC, Fink NE, Jaar BG, Sadler JH, Levin NW, Coresh J, Klag MJ, Powe NR. Attainment of clinical performance targets and improvement in clinical outcomes and resource use in hemodialysis care: a prospective cohort study. BMC Health Serv Res 7:5, 2007.
Zhang L, Kao WHL, Berthier-Schaad Y, Plantinga L, Fink N, Smith MW, Coresh J. C-reactive protein (CRP) haplotype predicts serum CRP levels but not cardiovascular disease in a dialysis cohort. AJKD, 49: 118-126, 2007.
Eisenberg L, Fink N, Niparko J for the CDaCI. Childhood development after cochlear implantation. ASHA Leader, 11:28-29, 2006.
Unruh ML, Buysse DJ, Dew MA, Evans IV, Wu AW, Fink NE, Powe NR, Meyer KB. Sleep quality and its correlates in the first year of dialysis. Clin J Am Soc Nephrol 1:802-810, 2006.
Plantinga LC, Jaar BG, Astor B, Fink NE, Eustace JA, Klag MJ, Powe NR. Association of clinic vascular access monitoring practices with clinical outcomes in hemodialysis patients. Nephron Clin Pract, 104:151-159, 2006.
Melamed ML, Eustace JA, Plantinga L, Jaar BG, Fink NE, Coresh J, Klag MJ, Powe NR. Changes in serum calcium, phosphate, and parathyroid hormone and the risk of death in incident dialysis patients: a longitudinal study. Kidney International, 70:351-357, 2006.
Eisenberg LS, Johnson KC, Martinez AS, Cokely CG, Tobey EA, Quittner AL, Fink NE, Wang NY, Niparko JK. Speech recognition at 1-year follow-up in the Childhood Development after Cochlear Implantation Study: Methods and preliminary findings. Audiol Neurotol 11:259-268, 2006.
Chretien JP, Coresh J, Berthier-Schaad Y, Kao WH, Fink N, Klag MJ, Marcovina SM, Giaculli F, Smith MW. Three single-nucleotide polymorphisms in LPA account for the majority of lipoprotein(A) level elevation in African Americans compared to European Americans. J Med Genet 43:917-923, 2006.
Zhang L, Kao WHL, Berthier-Schaad Y, Liu Y, Plantinga L, Jaar B, Fink N, Powe N, Klag M, Smith MW, Coresh J. Haplotype of signal transducer and activator of transcription 3 gene predicts cardiovascular disease in dialysis patients, JASN, 17-2285-2292, 2006 .
Liu Y, Berthier-Schaad Y, Fallin MD, Fink NE, Tracy RP, Klag MJ, Smith MW, Coresh J. Interleukin-6 haplotypes, inflammation and risks of CVD in a multiethnic dialysis cohort. JASN, 17:863-870, 2006.
Boulware LE, Liu Y, Fink NE, Coresh J, Ford DE, Klag MJ, Powe NR. Temporal relation among depression symptoms, cardiovascular disease events and mortality in end-stage renal disease: Contribution of reverse causality. Clin J Am Soc Nephrol, 1:496-504, 2006.
